|Videos|December 20, 2022
Interview with Anthony Carpanzano (AAPS 2022)
Author(s)Chris Spivey
Anthony Carpanzano, Director of R&D at JRS Pharma, discussed ongoing formulation challenges and trends.
KEY LEARNING OBJECTIVES
- Overcoming formulation challenges in converting liquids into solid dose,
- Turning soft gel into tablets, enhancing dissolution,
- Simplifying modified-release formulations
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Related Content
Trending on Pharmaceutical Technology
1
FDA Launches PreCheck Pilot Program to Bolster Domestic Drug Manufacturing
2
Women in STEM: Inspiration from Innovators in Pharma
3
Repertoire Immune Medicines and Lilly Collaborate on Treatments for Autoimmune Diseases
4
Six New Approvals and Nine Indication Extensions from EMA’s CHMP
5